Vanguard Capital Management
DARE icon

Vanguard Capital Management’s Dare Bioscience DARE Stock Holding History

Vanguard Capital Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
640,877
+178,572
+39% +$399K ﹤0.01% 3527
2026
Q1 		$841K Buy
+462,305
New +$791K ﹤0.01% 3584

Other funds holding DARE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Vanguard Capital Management's DARE Position: Q2 2026 in Review

Vanguard Capital Management increased its Dare Bioscience (DARE) stake by 39% in Q2 2026, buying an estimated $399K and bringing the position to 640,877 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3527.

Vanguard Capital Management first reported a position in DARE in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Vanguard Capital Management held 640,877 shares of Dare Bioscience worth $1.35M as of Q2 2026.
  • Vanguard Capital Management bought 178,572 Dare Bioscience shares in Q2 2026, an estimated $399K.
  • Dare Bioscience made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3527 holding.
  • Vanguard Capital Management first reported a position in Dare Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.